The most common gastrointestinal side effects include: Nausea : Reported in 15-44% of patients (higher rates at Wegovy 2.4 mg), typically most pronounced during dose escalation Diarrhea : Affects approximately 8-30% of users, ranging from mild to moderate severity Vomiting : Occurs in 5-24% of patients (higher rates at Wegovy 2.4 mg), often associated with rapid dose increases Abdominal pain : Experienced by 5-20% of patients, usually described as cramping or discomfort Constipation : Paradoxically affects 3-24% despite the medication's effects on motility Dyspepsia and gastroesophageal reflux : Related to delayed gastric emptying These effects result from semaglutide's pharmacologic action on GLP-1 receptors throughout the gastrointestinal tract
The role of mitochondria in metabolism and cell death
Ultimately, a holistic approach encompassing medication, lifestyle modifications, and ongoing support from healthcare providers offers the greatest potential for lasting weight management
Sauv's explanation is mechanistic, and it starts with a lesson from residency
After three weeks, women who received zinc supplements saw significant increases in IGF-1, but only if they were low in it at the start of the study
